Population Pharmacokinetics of Semaglutide for Type 2 Diabetes

Autor: Steen H. Ingwersen, Kristin C. Carlsson Petri, Thomas W. Anderson, Rune Viig Overgaard, Anne Flint, Philip Harder Delff
Jazyk: angličtina
Rok vydání: 2019
Předmět:
Zdroj: Diabetes Therapy
ISSN: 1869-6961
1869-6953
Popis: Introduction The aim of the present analysis was to characterise the absorption, distribution and elimination of semaglutide by means of population pharmacokinetic (PK) models using data from nine clinical pharmacology trials conducted in both healthy subjects and those with type 2 diabetes. Methods Data were obtained from trials with subcutaneous and intravenous administration of semaglutide that utilised frequent PK sampling and included a total of 353 subjects with 10,573 concentration values. Results Semaglutide PK properties across trials, drug product strengths and populations were well characterised by a two-compartment model with first-order absorption and elimination. For a typical subject with type 2 diabetes, clearance was estimated to be 0.0348 L/h [95% confidence interval (CI) 0.0327–0.0369 L/h], and the central and peripheral volumes were estimated to be 3.59 L (95% CI 3.28–3.90 L) and 4.10 L (95% CI 3.78–4.42 L), respectively (i.e. a total volume of distribution of 7.7 L). Interindividual variation was low (~ 15%) for both clearance and volumes of distribution, with low residual error (
Databáze: OpenAIRE
Nepřihlášeným uživatelům se plný text nezobrazuje